Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

2011
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2012 4
2013 8
2014 12
2015 12
2016 9
2017 19
2018 14
2019 13
2020 16
2021 20
2022 14
2023 14
2024 26
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

155 results

Results by year

Filters applied: . Clear all
Page 1
Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer.
Heidegger I, Fotakis G, Offermann A, Goveia J, Daum S, Salcher S, Noureen A, Timmer-Bosscha H, Schäfer G, Walenkamp A, Perner S, Beatovic A, Moisse M, Plattner C, Krogsdam A, Haybaeck J, Sopper S, Thaler S, Keller MA, Klocker H, Trajanoski Z, Wolf D, Pircher A. Heidegger I, et al. Mol Cancer. 2022 Jun 18;21(1):132. doi: 10.1186/s12943-022-01597-7. Mol Cancer. 2022. PMID: 35717322 Free PMC article.
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.
Pencik J, Philippe C, Schlederer M, Atas E, Pecoraro M, Grund-Gröschke S, Li WJ, Tracz A, Heidegger I, Lagger S, Trachtová K, Oberhuber M, Heitzer E, Aksoy O, Neubauer HA, Wingelhofer B, Orlova A, Witzeneder N, Dillinger T, Redl E, Greiner G, D'Andrea D, Östman JR, Tangermann S, Hermanova I, Schäfer G, Sternberg F, Pohl EE, Sternberg C, Varady A, Horvath J, Stoiber D, Malcolm TI, Turner SD, Parkes EE, Hantusch B, Egger G, Rose-John S, Poli V, Jain S, Armstrong CWD, Hoermann G, Goffin V, Aberger F, Moriggl R, Carracedo A, McKinney C, Kennedy RD, Klocker H, Speicher MR, Tang DG, Moazzami AA, Heery DM, Hacker M, Kenner L. Pencik J, et al. Among authors: heidegger i. Mol Cancer. 2023 Aug 12;22(1):133. doi: 10.1186/s12943-023-01825-8. Mol Cancer. 2023. PMID: 37573301 Free PMC article.
Challenging the Urologist of the Future: Time for a Change?
Stangl FP, Heidegger I, Kraft P, Lammers RJM, Horvath M, Deger MD, Polo-Alonso E, Wenzel M, Affentranger A, Schou-Jensen K, Ali L, Keenan RA, Gallardo-Zamora L, Alva JF, Trerè D, Tsampoukas G, Hoyerup P, Cerrato C, Raison N, Brookman-May S, Vásquez JL. Stangl FP, et al. Among authors: heidegger i. Eur Urol. 2024 May 29:S0302-2838(24)02393-5. doi: 10.1016/j.eururo.2024.05.018. Online ahead of print. Eur Urol. 2024. PMID: 38811312
Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter Study.
Kafka M, Giannini G, Artamonova N, Neuwirt H, Ofner H, Kramer G, Bauernhofer T, Luger F, Höfner T, Loidl W, Griessner H, Lusuardi L, Bergmaier A, Berger A, Winder T, Weiss S, Bauinger S, Krause S, Drerup M, Heinrich E, Schneider M, Madersbacher S, Vallet S, Stoiber F, Laimer S, Hruby S, Schachtner G, Nagele U, Lenart S, Ponholzer A, Pfuner J, Wiesinger C, Kamhuber C, Müldür E, Bektic J, Horninger W, Heidegger I. Kafka M, et al. Among authors: heidegger i. Clin Genitourin Cancer. 2024 Apr;22(2):458-466.e1. doi: 10.1016/j.clgc.2023.12.018. Epub 2024 Jan 4. Clin Genitourin Cancer. 2024. PMID: 38267304 Free article.
Drug-Drug Interactions in Prostate Cancer Treatment.
Hebenstreit D, Pichler R, Heidegger I. Hebenstreit D, et al. Among authors: heidegger i. Clin Genitourin Cancer. 2020 Apr;18(2):e71-e82. doi: 10.1016/j.clgc.2019.05.016. Epub 2019 May 27. Clin Genitourin Cancer. 2020. PMID: 31677899 Review.
Intravenous iron-induced hypophosphatemia and kidney stone disease.
Panzer M, Meindl E, Schaefer B, Wagner S, Glodny B, Mayer G, Pircher A, Schwarz C, Beckmann F, Hejny C, Joachim-Mrosko B, Konzett J, Tilg H, Heidegger I, Wolf M, Weiskirchen R, Zoller H. Panzer M, et al. Among authors: heidegger i. Bone Rep. 2024 Mar 29;21:101759. doi: 10.1016/j.bonr.2024.101759. eCollection 2024 Jun. Bone Rep. 2024. PMID: 38590391 Free PMC article.
Cytoreductive Radical Prostatectomy for Metastatic Hormone-sensitive Prostate Cancer-Evidence from Recent Prospective Reports.
Rajwa P, Zattoni F, Maggi M, Marra G, Kroyer P, Shariat SF, Briganti A, Montorsi F, Heidegger I, Gandaglia G; EAU-Young Academic Urologists (YAU) Prostate Cancer Working Party. Rajwa P, et al. Among authors: heidegger i. Eur Urol Focus. 2023 Jul;9(4):637-641. doi: 10.1016/j.euf.2023.01.011. Epub 2023 Jan 23. Eur Urol Focus. 2023. PMID: 36697321 Review.
Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression.
Papachristodoulou A, Heidegger I, Virk RK, Di Bernardo M, Kim JY, Laplaca C, Picech F, Schäfer G, De Castro GJ, Hibshoosh H, Loda M, Klocker H, Rubin MA, Zheng T, Benson MC, McKiernan JM, Dutta A, Abate-Shen C. Papachristodoulou A, et al. Among authors: heidegger i. Eur Urol. 2024 Apr;85(4):361-372. doi: 10.1016/j.eururo.2023.07.016. Epub 2023 Aug 31. Eur Urol. 2024. PMID: 37659962
Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblasts.
Eigentler A, Handle F, Schanung S, Degen A, Hackl H, Erb HHH, Fotakis G, Hoefer J, Ploner C, Jöhrer K, Heidegger I, Pircher A, Klotz W, Herold M, Schäfer G, Culig Z, Puhr M. Eigentler A, et al. Among authors: heidegger i. Oncogene. 2024 Jan;43(4):235-247. doi: 10.1038/s41388-023-02901-5. Epub 2023 Nov 29. Oncogene. 2024. PMID: 38017134 Free PMC article.
155 results